Glioblastoma survival in the United States before and during the temozolomide era. (Q44016219)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Glioblastoma survival in the United States before and during the temozolomide era (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Brian Patrick O'Neill

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Brian Patrick O'Neill

series ordinal

1 reference

29 November 2017

publication date

2 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

359-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Chemotherapy for brain tumors--a new beginning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Departures from community equipoise may lead to incorrect inference in randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

PCV chemotherapy for recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

A systematic review of physicians' survival predictions in terminally ill cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Primetime for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0749-4

The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22045118

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-011-0749-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22045118%20AND%20SRC:MED&resulttype=core&format=json